NRAS and fibrosis: Significantly decreased mRNA expression of N-RAS was observed in patients with early chronic liver disease (eCLD) with F2/F3 fibrosis score (Fig. 6C, cohort#2 [18]), compensated cirrhosis (CC), and with ACLD (cohort#3 [19]) (Fig. 6D).